THOUSAND
OAKS, Calif., June 5, 2024
/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman
Sachs 45th Annual Global Healthcare Conference at
9:20 a.m. ET on Monday, June 10,
2024. Peter Griffith, executive vice
president and chief financial officer at Amgen, and Jay Bradner, executive vice president of
Research and Development and chief scientific officer at Amgen,
will present at the conference. The webcast will be broadcast over
the internet simultaneously and will be available to members of the
news media, investors and the general public.
The webcast, as with other selected presentations regarding
developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's website,
www.amgen.com, under Investors. Information regarding presentation
times, webcast availability and webcast links are noted on Amgen's
Investor Relations Events Calendar. The webcast will be archived
and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops,
manufactures and delivers innovative medicines to help millions of
patients in their fight against some of the world's toughest
diseases. More than 40 years ago, Amgen helped to establish the
biotechnology industry and remains on the cutting-edge of
innovation, using technology and human genetic data to push beyond
what's known today. Amgen is advancing a broad and deep pipeline
that builds on its existing portfolio of medicines to treat cancer,
heart disease, osteoporosis, inflammatory diseases and rare
diseases.
In 2024, Amgen was named one of the "World's Most Innovative
Companies" by Fast Company and one of "America's Best Large
Employers" by Forbes, among other external recognitions. Amgen
is one of the 30 companies that comprise the Dow Jones Industrial
Average®, and it is also part of the Nasdaq-100
Index®, which includes the largest and most innovative
non-financial companies listed on the Nasdaq Stock Market based on
market capitalization.
For more information, visit Amgen.com and follow Amgen on X,
LinkedIn, Instagram, TikTok, YouTube and Threads.
CONTACT: Amgen, Thousand
Oaks
Elissa Snook, 609-251-1407
(media)
Justin Claeys, 805-313-9775
(investors)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-goldman-sachs-45th-annual-global-healthcare-conference-302164003.html
SOURCE Amgen